Evaluation of gingival inflammation related to different retraction agents / 华西口腔医学杂志
West China Journal of Stomatology
; (6): 53-55, 2008.
Article
en Zh
| WPRIM
| ID: wpr-296718
Biblioteca responsable:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To choose the best retraction agent for the clinic by evaluating the gingival inflammation related to three kinds of retraction agents.</p><p><b>METHODS</b>40 maxillary premolars were divided into four groups according to the randomized block design: Ferric sulfate group, aluminum chloride group, epinephrine group, sodium chloride group(control group), each 10 teeth, respectively used 25% AlCl3, 15.5% Fe2(SO4)3, 0.1% HCl-epinephrine, sodium chloride as retraction agents. The quantity of gingival crevicular fluid (GCF) and the active level of aspartate amino-transferase (AST) in gingival crevicular fluid were measured before and 1, 3, 5, 7, 9 days after retracting gingiva by four kinds retraction agents. The changes of GCF were calculated.</p><p><b>RESULTS</b>The change of the GCF from the smallest to the largest was sodium chloride, 0.1% HCl-epinephrine, 25% AlCl,, 15.5% Fe2 (SO)3. Compared with sodium chloride, only 15.5% Fe2 (SO)3 in AST was the significant difference in the first day and the third day (P < 0.05). AST of ferric sulfate group after 1, 3 days greater than 800 IU.</p><p><b>CONCLUSION</b>0.1% HCl-epinephrine is suggested in patient without cardiovascular disease. For patient with cardiovascular disease, the better substitute is 25% AlCl3. 15.5% Fe2 (SO4)3 will not be used until its concentration is fallen.</p>
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Epinefrina
/
Cloruros
/
Líquido del Surco Gingival
/
Compuestos de Aluminio
/
Encía
/
Incisivo
/
Inflamación
Tipo de estudio:
Clinical_trials
Límite:
Humans
Idioma:
Zh
Revista:
West China Journal of Stomatology
Año:
2008
Tipo del documento:
Article